H-Index
34
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
call: +1.631.629.4327
Mon-Fri 10 am - 2 pm EST

Logo

Medical Science Monitor Basic Research
MSMbanner

AmJCaseRep
MedSciTechnol

eISSN: 2329-0358

Procalcitonina, New Indicator for Non-Viral Infections in Heart, Lung or Liver Transplant Patients.

S Hammer, P Fraunberger, B Meiser, M Stangl, D Seidel, C Hammer

Ann Transplant 1999; 4(2): 5-9

ID: 497446

Available online: 1999-06-11

Published: 1999-06-11


PCT is a highly specific analyse which shows significJ1t diagnostic validities when non-viral infections are compared with rejection episodes. PCT discriminates inflammatory events such as rejec:tion or viral infections and non-viral infections including bacterial, fungal and protozoal infections. The half-life of PCT is 24 h indicating a cle< rly competent antibiotic treatment. PCT provides vital information early to clinicians and allows them to improve the management of bacteri.1l/fungal infection in immunocompromized transplant patients. PCT thus facilitates and improves the outcome of survival rate and the quality of life in the postoperative period of patients with heart, lung or liver grafts.

Keywords: procalcitonin, acute rejection, Infection, Transplantation



Back